Related Experiment Video
Updated: Feb 19, 2026

11:28
Biofunctionalized Prussian Blue Nanoparticles for Multimodal Molecular Imaging Applications
Published on: April 28, 2015
10.8K
Photoswitchable imaging contrast agents as an emerging frontier in precision bioimaging
Xiaoqiong Tan1,2, Qiankun Ni3, Ting Luo3
1State Key Laboratory of Organic-Inorganic Composites, Beijing Laboratory of Biomedical Materials, College of Materials Science and Engineering, Beijing University of Chemical Technology, Beijing 100029, P. R. China. chenghb@mail.buct.edu.cn.
Chemical Society Reviews
|February 17, 2026
Summary
Photoswitchable imaging contrast agents (PICAs) offer advanced bioimaging by enabling background suppression and continuous imaging. This review explores PICA innovations and strategies to overcome challenges for broader applications.
Area of Science:
- Molecular Imaging
- Photochemistry
- Biotechnology
Background:
- Photoswitchable molecules undergo reversible photoisomerization, enabling unique photophysical properties.
- Photoswitchable imaging contrast agents (PICAs) leverage these properties for enhanced bioimaging.
- PICAs offer advantages like background suppression, continuous imaging, and rapid signal modulation.
Purpose of the Study:
- To comprehensively analyze advancements and challenges of PICAs in bioimaging.
- To propose innovative molecular design and assembly strategies for PICA improvement.
- To summarize recent PICA progress across various imaging modalities.
Main Methods:
- Systematic evaluation of representative photoswitchable molecules as PICAs.
- Analysis of molecular design and assembly strategies to address limitations.
- Review of PICA applications in fluorescence, phosphorescence, photoacoustic, MRI, and Raman imaging.
Main Results:
- PICAs demonstrate significant potential for improving bioimaging quality and precision.
- Key challenges include hydrophobicity, short-wavelength excitation, and suboptimal emission.
- Progress has been made in diverse imaging techniques, enhancing diagnostic capabilities.
Conclusions:
- PICAs represent a promising frontier in bioimaging, offering superior performance over conventional agents.
- Overcoming current limitations through molecular design is crucial for widespread clinical adoption.
- Future PICA development will drive advancements in both preclinical research and clinical diagnostics.

